← Leaderboards
Peter R Reczek
Eva Pharmaceutical, Llc.
$816,789
Attributed
$816,789
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $446.6K · FY2008–09$500K$375K$250K$125K$0
'08
'09
Funding mix
By agency
NIH$816,789 · 1
By mechanism
R42$816,789 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Dinoprostone”
- Joshua A Boyce · Brigham And Women'S Hospital$19,400,081
- Katrin I Andreasson · Johns Hopkins University$13,944,672
- Marc L Peters-Golden · University Of Michigan At Ann Arbor$12,249,968
- Sanford D Markowitz · Case Western Reserve University$10,193,910
- Raymond J Dingledine · Emory University$9,284,867
- Raymond Nelson Dubois · Vanderbilt University$7,830,543
Research focus
DinoprostoneDoseCyclooxygenase InhibitorsAbstractingAdverse EffectsAnti-InflammatoryAnti-Inflammatory AgentsCyclooxygenase 1BaseBiological FactorsAnimalsBrainCancerousCancer TherapyCanis FamiliarisCelecoxibAnalogChronicCoagulation ProcessCollaborationsCollagenConsumptionContractsDrug Kinetics